A pilot study: 131I-antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost von Reardon, David A, Zalutsky, Michael R, Akabani, Gamal, Coleman, R Edward, Friedman, Allan H, Herndon, 2nd, James E, McLendon, Roger E, Pegram, Charles N, Quinn, Jennifer A, Rich, Jeremy N, Vredenburgh, James J, Desjardins, Annick, Guruangan, Sridharan, Boulton, Susan, Raynor, Renee H, Dowell, Jeanette M, Wong, Terence Z, Zhao, Xiao-Guang, Friedman, Henry S, Bigner, Darell D

Volltext

Salvage Radioimmunotherapy With Murine Iodine-131–Labeled Antitenascin Monoclonal Antibody 81C6 for Patients With Recurrent Primary and Metastatic Malignant Brain Tumors: Phase II... von REARDON, David A, AKABANI, Gamal, RICH, Jeremy N, VREDENBURGH, James J, DESJARDINS, Annick, GURUANGAN, Sri, BADRUDDOJA, Michael, DOWELL, Jeanette M, WONG, Terence Z, ZHAO, Xiao-Guang, ZALUTSKY, Michael R, BIGNER, Darell D, COLEMAN, R. Edward, FRIEDMAN, Allan H, FRIEDMAN, Henry S, HERNDON, James E, MCLENDON, Roger E, PEGRAM, Charles N, PROVENZALE, James M, QUINN, Jennifer A

Volltext